Merck sales rise 5% to $12.5B in Q4

Thursday, 04. February 2021 12:50

American pharmaceutical company Merck & Co., Inc. said on Thursday its fourth-quarter worldwide sales increased 5% to $125 billion.

Meanwhile, loss per share during the same period landed at $0.83, reflecting charges related to acquisitions and intangible asset impairments. Full-year 2020 worldwide sales were $48.0 billion, which represents an increase of 2%. Excluding the impact from foreign exchange, sales grew by 4%.

"Despite extraordinary challenges brought on by the COVID-19 pandemic, Merck achieved solid growth and made meaningful progress in our pipeline in 2020. We remain focused on our science-led strategy and are confident that this approach will continue to deliver value to patients and shareholders," CEO Kenneth C. Frazier commented on the results. Also, the company announced that Frazier will retire as the company’s CEO, effective June 30.

Related Links: Merck KGaA
Breaking the News / TF